Abstract:Background Bladder cancer results from complex interactions between many genetic and environment factors. The polymorphism Ser326Cys in hOGG1 gene has been reported to be associated with bladder cancer in some studies, though the results remain inconclusive. To explore this relationship of hOGG1 polymorphism and the susceptibility for bladder cancer and the impact of smoking exposures, a cumulative meta-analysis was performed in this study. Methods We extracted the data from the Pubmed database up to January 9, 2012 using the search phrases “ hOGG1 , Ser326Cys polymorphism and bladder cancer”. Seven case–control studies were identified, including 2474 patients and 2408 controls. Four of them provided the analysis of smoking effects, with 1372 smokers and 947 non-smokers. The odds ratios (ORs) and associated 95 % confidence intervals (CIs) were calculated using fixed- or random- effects models. Results Regarding the overall association between the hOGG1 326Cys allele and bladder cancer risk, the meta-analysis did not reveal a significant effect in the additive model (OR: 1.06, 95 % CI: 0.96-1.26; p = 0.49), the recessive genetic model (OR: 1.05, 95 % CI: 0.65-1.70; p = 0.85) or the dominant genetic model (OR: 1.07, 95 % CI: 0.87-1.32; p = 0.53). Similarly, no significant relationship was observed in the stratified analysis by ethnicity, study design and Hardy-Weinberg equilibrium (all p > 0.05). In the non-smokers, however, hOGG1 326Cys allele significantly increased the risk for bladder cancer and the ORs in the additive model, homozygote contrast and recessive genetic model were 1.59 ( p = 0.02), 2.53( p = 0.003) and 2.41( p = 0.0005), respectively. Nevertheless, in the smoker subgroup, similar findings could not be found in all genetic models (all p > 0.05). Conclusions The association between the hOGG1 326Cys allele and bladder cancer was significant in non-smoker population, while was non-detectable in common or smoker populations. This meta-analysis suggests that the hOGG1 Ser326Cys polymorphism may be a risk factor for bladder cancer without exposure to smoking. Further functional studies are needed to elucidate the gene polymorphism-bladder cancer relationship and gene-environment interactions.

Lack Of Association Between Hogg1 Ser326cys Polymorphism And The Risk Of Bladder Cancer: A Meta-Analysis

Correlation of Interleukin-10-1082G/A Single Nucleotide Polymorphism to the Susceptibility of Bladder Cancer

Association of Base Excision Repair Gene Hogg1 Ser326Cys Polymorphism with Susceptibility to Cervical Squamous Cell Carcinoma and High-Risk Human Papilloma Virus Infection in a Chinese Population.

An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis

The Hogg1 Ser326Cys Gene Polymorphism and Susceptibility for Bladder Cancer: a Meta-Analysis

Lack of Association Between the Hogg1 Ser326Cys Polymorphism and Gastric Cancer Risk: a Meta-Analysis.

Lack of Association Between the Hogg1 Ser326Cys Polymorphism and Breast Cancer Risk: Evidence from 11 Case–control Studies

The Hogg1 Ser326Cys Polymorphism and Esophageal Cancer Risk: a Meta-Analysis of 1,875 Cancer Cases and 3,041 Controls

Association between Genetic Polymorphism of Interleukin-10-819 C>T and Susceptibility of Bladder Cancer Among Han Nationality in Zhejiang

The Effect Of Hogg1 Ser326cys Polymorphism On Cancer Risk: Evidence From A Meta-Analysis

Lack of association between the hOGG1 gene Ser326Cys polymorphism and gastric cancer risk: evidence from a case-control study and a meta-analysis.

The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.

Association of Hogg1 Ser326Cys Polymorphism with Susceptibility to Hepatocellular Carcinoma.

Erratum To: Association of Hogg1 Ser326Cys Polymorphism with Gastric Cancer Risk: a Meta-Analysis

hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis

Hogg1 Ser326cys Polymorphism And Risk Of Hepatocellular Carcinoma Among East Asians: A Meta-Analysis

HOGG1 Ser326Cys Polymorphism and Susceptibility to Head and Neck Cancer: a Meta-Analysis.

A Meta-Analysis of the Association Between the Hogg1 Ser326Cys Polymorphism and the Risk of Esophageal Squamous Cell Carcinoma

Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk

Association Between the OGG1 Ser326Cys Polymorphism and Cancer Risk: Evidence from 152 Case-Control Studies

Meta analysis of association between Ser326Cys polymorphism of hOGG1 gene and risk of lung cancer]